C209 (Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg)
Pill with imprint C209 is Blue, Capsule-shape and has been identified as Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg. It is supplied by Cipla USA, Inc.
Emtricitabine/tenofovir is used in the treatment of pre-exposure prophylaxis; occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Emtricitabine/tenofovir 200 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C209
Emtricitabine and Tenofovir Disoproxil Fumarate
- Imprint
- C209
- Strength
- 200 mg / 300 mg
- Color
- Blue
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA, Inc.
- Manufacturer
- Appco Pharma LLC
- National Drug Code (NDC)
- 69097-0209
Related images for "C209"
More about emtricitabine / tenofovir
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (36)
- Drug images
- Drug class: antiviral combinations
Patient resources
- Drug Information
- Emtricitabine and tenofovir (Advanced Reading)
- Emtricitabine and Tenofovir Disoproxil Fumarate
Other brands
Truvada, AccessPak for HIV PEP Basic
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.